Editas Medicine (EDIT) Share-based Compensation Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) Share-based Compensation Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -89.90% |
| Dec 31, 2024 | -36.04% |
| Sep 30, 2024 | 250.94% |
| Jun 30, 2024 | -230.22% |
| Mar 31, 2024 | 68.29% |
| Dec 31, 2023 | -148.53% |
| Sep 30, 2023 | -19.55% |
| Jun 30, 2023 | -21.20% |
| Mar 31, 2023 | -60.57% |
| Dec 31, 2022 | 60.79% |
| Sep 30, 2022 | -41.26% |
| Jun 30, 2022 | 1,158.17% |
| Mar 31, 2022 | -6.33% |
| Dec 31, 2021 | -311.63% |
| Sep 30, 2021 | 71.26% |
| Jun 30, 2021 | 50.29% |
| Mar 31, 2021 | 96.21% |
| Dec 31, 2020 | 130.11% |
| Sep 30, 2020 | -10.87% |
| Jun 30, 2020 | 23.67% |